Baron Funds released their Q3 2024 investor letter for the Baron Health Care Fund, reporting a 5.81% appreciation in the quarter. Vaxcyte, Inc. was highlighted as a top pick, with a one-month return of -4.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing